PubRank

Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers (THS)

Clinical Trial ID NCT00236301

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00236301

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002 80.37
2 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000 18.04
3 The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999 6.25
4 Menopause and the risk of coronary heart disease in women. N Engl J Med 1987 4.70
5 Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 3.08
6 Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001 3.03
7 Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation 1999 2.31
8 Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999 1.96
9 Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999 1.89
10 Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999 1.39
11 Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol 1997 1.21
12 Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis. Arterioscler Thromb Vasc Biol 2000 0.93
13 Hormone replacement therapy and plasma homocysteine levels. Obstet Gynecol 1999 0.85
14 Hormone replacement therapy and circulating ICAM-1 in postmenopausal women--a randomised controlled trial. Thromb Haemost 1999 0.83
15 Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol. Fertil Steril 1995 0.80
Next 100